New global study launches to measure steroid safety in pregnant women

Researchers have established an international birth cohort to track long-term outcomes of antenatal corticosteroid use—a decades-old treatment given to prevent complications in at-risk pregnancies. The study could reshape clinical guidelines and inform pharmaceutical liability strategies by providing definitive evidence on benefits versus risks during pregnancy and childhood development.

Originaltitel: Consortium for the Study of Pregnancy Treatments (Co-OPT): An international birth cohort to study the effects of antenatal corticosteroids